
The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats
Keywords: DMSO; ACh; acetylcholine; AGE; advanced glycation end products; ALDH-2; mitochondrial aldehyde dehydrogenase; CCL-2; see MCP-1; ChIP; chromatin immunoprecipitation; COX2; cyclooxygenase-2; CRP; C-reactive protein; DHE; dihydroethidine; DHFR; dihydrofolate reduc